In a strategic move that signals a paradigm shift in how chronic cardiovascular conditions are managed, Vivos Therapeutics Inc. and South Palm Cardiovascular Associates LLC (SPCVA) have officially entered into a definitive collaboration. This partnership aims to establish a state-of-the-art "Sleep & Airway Medicine Center" in Palm Beach County, Florida, effectively integrating specialized sleep apnea treatment into the mainstream cardiology workflow.
The collaboration represents a bold departure from the fragmented healthcare models that have historically separated sleep medicine from cardiovascular care. By aligning Vivos’ proprietary, FDA-cleared airway technology with the clinical reach of a major, physician-owned cardiology group, the partners intend to tackle the prevalence of obstructive sleep apnea (OSA) among cardiac patients, a cohort where undiagnosed or poorly managed sleep disorders often exacerbate systemic health issues.
The Strategic Framework: AIM Florida LLC
The cornerstone of this partnership is the creation of AIM Florida LLC, a physician-aligned management services organization (MSO). Under the terms of the agreement, Vivos Therapeutics is slated to hold a 75% majority interest in the new entity, subject to final regulatory approvals.
This MSO structure is designed to provide the administrative, operational, and clinical infrastructure necessary to scale sleep medicine services within a high-volume cardiology environment. By centralizing management, Vivos and SPCVA aim to streamline the patient journey, ensuring that cardiovascular patients who require sleep intervention do not fall through the cracks of the healthcare system.
Chronology: A Roadmap to 2027
The timeline for this initiative is ambitious, reflecting the urgency both parties feel regarding the management of OSA in high-risk patients.
- Q3/Q4 2024: The formal signing of definitive collaboration and operating agreements. Both organizations have begun the process of defining the corporate governance and operational structure of AIM Florida LLC.
- Late 2024–2025 (Site Selection and Infrastructure): The partners are currently in the active phase of evaluating real estate options in Palm Beach County. This phase involves rigorous site selection to ensure proximity to existing SPCVA patient bases, followed by lease negotiations and architectural planning.
- 2026 (Build-out and Regulatory Compliance): The year is earmarked for facility construction, the acquisition of advanced medical equipment, and the navigation of local and state licensing requirements. This period will also involve a major talent acquisition drive to staff the facility with board-certified sleep specialists, technicians, and administrative support.
- Q1 2027 (Go-Live): The target for the commencement of clinical operations. The initial operational plan anticipates a capacity to treat approximately 250 patients per month, with a built-in scalability mechanism that allows for the rapid addition of clinical teams as patient demand grows.
The Clinical Imperative: Why Cardiology Needs Sleep Medicine
The motivation behind this partnership is rooted in clinical necessity. SPCVA is a significant, multi-location cardiology practice in Florida, serving a population of approximately 30,000 patients. Many of these patients suffer from chronic heart conditions where OSA acts as a silent, often unrecognized, force multiplier for morbidity.
Supporting Data and Patient Realities
The correlation between OSA and cardiovascular disease is well-documented in medical literature. Patients with sleep apnea suffer from intermittent hypoxia (low oxygen levels) during the night, which triggers systemic inflammation, increases blood pressure, and places additional strain on the heart muscle.
Dr. Andres Ruiz, a leading cardiologist at SPCVA, highlighted the frustration that led to this partnership: "As cardiologists caring for tens of thousands of chronically ill patients throughout South Florida, we see the impact of obstructive sleep apnea every day. We have witnessed the full spectrum—from patients with mild disease who were historically managed with a watch-and-wait approach, to those with severe OSA who struggled to achieve consistent compliance with traditional therapies."
The current standard of care for OSA—primarily CPAP (Continuous Positive Airway Pressure) therapy—has historically suffered from low patient compliance rates. When patients fail to use their CPAP machines, their sleep apnea remains untreated, leaving their underlying cardiovascular risks unmitigated. By offering a broader array of treatments—including oral appliances, laser therapy, and myofunctional therapy—the new center hopes to bridge this "compliance gap."
Official Responses and Strategic Vision
The leadership of both organizations views this partnership as a blueprint for the future of specialized care.
R. Kirk Huntsman, Chairman and CEO of Vivos
For Vivos Therapeutics, this partnership is a validation of their business model. "The execution of these definitive agreements is an important milestone in our strategy to partner directly with larger medical specialty groups and support their patients’ sleep and airway needs," Huntsman noted in the official press release. He emphasized that the combination of SPCVA’s established patient trust and Vivos’ technological portfolio creates a "scalable and capital-efficient model for growth."
Dr. Andres Ruiz, Lead Cardiologist at SPCVA
Dr. Ruiz underscored the clinical shift. "When Vivos introduced us to their FDA-cleared approach to OSA testing and treatment, we recognized an important opportunity to address this condition more directly and effectively. We believe that identifying and treating OSA can play a meaningful role in improving our patients’ overall health and outcomes."
Implications: A New Era for Integrated Healthcare
The establishment of the Sleep & Airway Medicine Center has several far-reaching implications for the medical community in Florida and beyond.
1. Reducing Patient Attrition
One of the greatest challenges in modern healthcare is the "referral leak." When a cardiologist refers a patient to a separate sleep clinic, the likelihood of the patient following through, obtaining a diagnosis, and adhering to a treatment plan often drops significantly. By integrating these services under one umbrella, AIM Florida intends to reduce patient confusion and attrition, ensuring that the treatment loop is closed effectively.
2. A Multimodal Approach to Therapy
Unlike traditional sleep centers that may focus heavily on one or two diagnostic pathways, this facility is designed to be comprehensive. The integration of:
- Advanced Sleep Testing: Faster, more accurate diagnostic tools.
- FDA-cleared Oral Appliances: A non-invasive alternative for those who cannot tolerate CPAP.
- Laser and Myofunctional Therapy: Addressing the anatomical root causes of airway obstruction rather than just managing symptoms.
3. Scalability and Future Expansion
If the Palm Beach County pilot succeeds in its goal of managing 250 patients per month, the model could serve as a replicable template for Vivos across other major medical centers in the United States. The "physician-aligned management services organization" model is designed to be lean, leveraging existing medical groups’ patient volume to keep acquisition costs low and operational efficiency high.
4. Improving Long-Term Cardiovascular Outcomes
Ultimately, the goal is to see a measurable improvement in the quality of life and longevity of the 30,000+ patients in the SPCVA network. By addressing the "silent" culprit of OSA, the cardiology team hopes to improve their patients’ blood pressure control, reduce the frequency of heart-related events, and improve the efficacy of their primary cardiac treatments.
Conclusion
The partnership between Vivos Therapeutics and South Palm Cardiovascular Associates represents a significant step toward "whole-patient" care. By embedding sleep medicine directly into the cardiology practice, the two organizations are not merely adding a new service line; they are attempting to solve a chronic, systemic failure in the management of sleep-disordered breathing. As the industry watches the development of the Palm Beach center, the success of this model could very well determine the future direction of integrated specialty care in the United States.
